*Corresponding Author:
Ehsan Shahverdi,
Blood Transfusion Research Center, High Institute for Research and Education in Transfusion Medicine, Tehran, Iran
Tel: +982188601606
E-mail: shahverdi_ehsan@yahoo.com
According to data from questionnaire answered by 39% of physicians [1]. Based on these data, intensive education about the best treatment of hypertension in elders seems necessary. More than 50% of Americans between the ages of 65 and 75 years and more than 70% of those aged 75 years and older have hypertension [2]. In about 60% of these persons with hypertension, isolated systolic hypertension is the most prominent [3]. Hypertension is reported in 57% of men and 60% of women with a mean age of 80 years [4]. Systolic and diastolic hypertension and isolated systolic hypertension were present in 20% and 37% of these men and 21% and 39% of these women respectively [4]. Mendelssohn reported high incidence of hypertension in different races too [5].
The higher the systolic or diastolic blood pressure in older persons increases the morbidity and mortality from cardiovascular disease in this group [6]. Increased systolic blood pressure is a better predictor and a stronger risk factor than increased diastolic blood pressure for morbidity and mortality in older persons due to cardiovascular disease [7].
In the Cardiovascular Health Study it was concluded that systolic blood pressure >169 mm Hg increased the mortality rate 2.4 times [8]. Hypertension in elders is a major risk factor for some diseases such as new coronary events, stroke and for congestive heart failure (CHF) [9-11]. Based on a meta-analysis, antihypertensive treatment reduced the incidence of strokes by about 30% and of new coronary events by about 20% and CHF by 39% [12]. In the Elderly Program, in the Systolic Hypertension, step 1 drug include chlorthalidone, 12.5 mg-25 mg daily, and the step 2 drug, atenolol, 25 mg-50 mg daily, caused a 49% reduction in the development of CHF [13].
We agree that according to the Sixth Report of the Joint National Committee on Detection, Evaluation, and Treatment of Hypertension (JNC VI), the aim of the hypertension therapy in older persons is to reduce the blood pressure to <140/90 mm Hg. In patients with diastolic hypertension, diastolic blood pressure should be decreased to 80-85 mm Hg [14].
JNC VI recommends that diuretics or beta blockers should be used as initial treatment in patients with hypertension and no associated medical conditions [14]. But it should be mentioned that older persons with hypertension have a very high prevalence of associated medical conditions. The antihypertensive drugs administered to these persons should be selected depends on their associated medical conditions.
Beta blockers and Angiotensin-Converting Enzyme (ACE) inhibitors should be used in patients with prior myocardial infarction and these patients should not treat with calcium channel blockers or alpha blockers [15]. It is confirmed that in patients with prior myocardial infarction and hypertension treatment with beta blockers, ACE inhibitors, diuretics, calcium channel blockers, or alpha blockers, the incidence of new coronary events in persons treated with one antihypertensive drug was lowest in persons treated with beta blockers or ACE inhibitors [15]. In older persons treated with two antihypertensive drugs, the incidence of new coronary events was lowest in persons treated with beta blockers plus ACE inhibitors [15].
Several studies confirmed the role of beta blockers in decreasing coronary events in patients with prior myocardial infarction is especially increased in persons with Diabetes Mellitus (DM) [16], abnormal Left Ventricular Ejection Fraction (LVEF) [17], and with CHF with abnormal LVEF or normal LVEF [18]. As a treatment in older persons with hypertension who have angina pectoris, myocardial ischemia, atrial fibrillation with a rapid ventricular rate, hyperthyroidism, preoperative hypertension, migraine, or essential tremor, beta blockers should also be used [19,20]. The hypertensive drug should be begin at the lowest dose and increased to the maximum dose. If there was no response to the initial drug, after reaching the full dose of drug, a second drug from another class should be started. In the case of significant adverse effects, a drug from another class should be substituted.
A diuretic is an initial drug routinely, but if it is not the initial drug, it is usually used as the second drug. A third drug from another class should be added, if the antihypertensive response was insufficient after reaching the full dose of two classes of drugs. In addition to appropriate treatment, in patients with hypertension cigarette smoking must be stopped. Diet and exercise should be used to reduce weight in overweight persons. According to Adler et al. study, each 10 mm Hg reduction in mean systolic blood pressure is associated with a significant 11% reduction in myocardial infarction risk. It seems vital to treat hyperlipidemia in old patients with hypertension [21].
References
- Hajjar I, Miller K, Hirth V (2002) Age-Related Bias in the Management of Hypertension: A National Survey of Physicians’ Opinions on Hypertension in Elderly J Gerontol A Biol Sci Med Sci 57: 487-491.
- Wolz M, Cutler J, Roccella EJ, Rohde F, Thom T, et (2000) Statement from the national high blood pressure education program: prevalence of hypertension. Am J Hypertens 13: 103-104.
- Franklin SS, Jacobs MJ, Wong ND, Gilbert J, Lapuerta P (2001) Predominance of isolated systolic hypertension among middle-aged and elderly US hypertensives: Analysis based on National Health and Nutrition Examination Survey (NHANES) III. Hypertension 37: 869-874.
- Aronow WS, Ahn C, Gutstein H (2002) Prevalence and incidence of cardiovascular disease in 1160 older men and 2464 older women in a long-term health care J Gerontol A Biol Sci Med Sci 57: 45-46.
- Mendelson G, Ness J, Aronow WS (1999) Drug Treatment of Hypertension in Older Persons in an Academic Hospital-Based Geriatrics Practice. J Am Geriatr Soc 47: 597-599.
- Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, et al. (2003) Seventh report of the joint national committee on prevention, detection, evaluation, and treatment of high blood Hypertension 42: 1206-1252.
- Rigaud AS, Forette B (2001) Hypertension in older adults. J Gerontol A Biol Sci Med Sci 56: 217-225.
- Fried LP, Kronmal RA, Newman AB, Bild DE, Mittelmark MB, et al. (1998) Risk factors for 5-year mortality in older adults: the Cardiovascular Health JAMA 279: 585-592.
- Aronow WS, Ahn C (1996) Risk factors for new coronary events in a large cohort of very elderly patients with and without coronary artery disease. Am J Cardiol 77: 864-866.
- Aronow WS, Ahn C (2002) Risk factors for new atherothrombotic brain infarction in older Hispanic men and women. J Gerontol A Biol Sci Med Sci 57: 61-63.
- Shahverdi E, Dadjoo Y, Farahani MM, Taghipoor H, Noori MK, et al. (2016) Coronary Bypass Occlusion and Predisposing Factors. Research in Cardiovascular Medicine.
- Gueyffier F, Bulpitt C, Boissel JP, Schron E, Ekbom T, et (1999) Antihypertensive drugs in very old people: a subgroup meta-analysis of randomised controlled trials. Lancet 353: 793-796.
- Kostis JB, Davis BR, Cutler J, Grimm RH, Berge KG, et al. (1997) Prevention of heart failure by antihypertensive drug treatment in older persons with isolated systolic JAMA 278: 212-216.
- Hansson L, Zanchetti A, Carruthers SG, Dahlöf B, Elmfeldt D, et al. (1998) Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: principal results of the Hypertension Optimal Treatment (HOT) randomised trial. Lancet 351: 1755-1762.
- Aronow WS, Ahn C (2002) Incidence of new coronary events in older persons with prior myocardial infarction and systemic hypertension treated with beta blockers, angiotensin-converting enzyme inhibitors, diuretics, calcium antagonists, and alpha Am J Cardiol 89: 1207-1209.
- Aronow WS, Ahn C (2001) Effect of beta blockers on incidence of new coronary events in older persons with prior myocardial infarction and diabetes The American journal of cardiology 87: 780-781.
- Aronow WS, Ahn C, Kronzon I (2001) Effect of beta blockers alone, of angiotensin-converting enzyme inhibitors alone, and of beta blockers plus angiotensin-converting enzyme inhibitors on new coronary events and on congestive heart failure in older persons with healed myocardial infarcts and asymptomatic left ventricular systolic dysfunction. Am J Cardiol 88: 1298-1300.
- Group MHS (1999) Effect of metoprolol CR/XL in chronic heart failure: metoprolol CR/XL randomised intervention trial in Congestive heart failure (MERIT-HF). Lancet 353: 2001-2007.
- Aronow WS, Frishman WH (2004) Angina in the elderly. Fundamental and Clinical Cardiology 48: 273-296.
- Aronow WS, Ahn C, Mercando AD, Epstein S, Kronzon I (1994) Decrease in mortality by propranolol in patients with heart disease and complex ventricular arrhythmias is more an anti-ischemic than an antiarrhythmic effect. Am J Cardiol 74: 613-615.
- Aronow WS, Ahn C, Gutstein H (2002) Incidence of new atherothrombotic brain infarction in older persons with prior myocardial infarction and serum low-density lipoprotein cholesterol ≥125 mg/dL treated with statins versus no lipid-lowering J Gerontol A Biol Sci Med Sci 57: 333-335.
Citation: Shahverdi E, Khani MA (2016) What is the Best Treatment for Hypertension in Old Patients? J Cardio Cardiovasu Med 1: 001.
Copyright: © 2016 Shahverdi E. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.


